🩸

Overview of Von Willebrand Disease

Feb 27, 2025

Von Willebrand Disease Lecture Notes

Introduction

  • Von Willebrand Disease (vWD): Most common inherited bleeding disorder.
  • Affects about 1% of the population.
  • Equally affects men and women.
  • Inherited through autosomal dominant and recessive patterns.
  • Caused by mutations in the von Willebrand factor (VWF) gene located on chromosome 12.

Function of Von Willebrand Factor (VWF)

  • Hemostasis: Critical in platelet aggregation and adhesion.
  • Platelet Receptor: Binds to glycoprotein 2b3a (GP2b3a) on platelets.
    • Facilitates platelet aggregation by binding multiple platelets.
  • Additional Roles:
    • Acts as a chaperone for factor VIII.
    • Regulates angiogenesis.
    • Important in bone metabolism, inhibits rank L-induced osteoclastogenesis.

Von Willebrand Factor Structure

  • Located in Weibel-Palade bodies in the endothelium.
  • Released into circulation.
  • Exists as multimers of varying sizes.
    • Larger multimers critical for platelet aggregation and adhesion.

Clinical Features of vWD

  • Bleeding History: Generally mucocutaneous bleeds.
    • Gingival bleeds, epistaxis (nosebleeds), menorrhagia.
  • Additional Features: Easy bruising, gastrointestinal bleeding, post-operative bleeding, immediate bleeding after trauma.
  • Type 3 vWD: More severe with musculoskeletal bleeding.

Types of Von Willebrand Disease

  • Type 1: Mild quantitative defect (80% of cases); autosomal dominant.
  • Type 2: Qualitative/functional defect with subtypes:
    • 2A: Impaired multimerization.
    • 2B: Hyperfunctional platelet binding.
    • 2M: Decreased glycoprotein 1B binding.
    • 2N: Decreased factor VIII binding.
  • Type 3: Severe, total quantitative defect; autosomal recessive.

Diagnosis

  • Tests:
    • CBC for platelet count.
    • INR and PTT.
    • VWF activity and antigen levels.
    • Factor VIII levels.
    • Genetic testing.
  • Blood Type Consideration:
    • Blood type O: Generally lower VWF levels.
    • Blood type AB: Higher VWF levels.

Treatment

  • Desmopressin (DDAVP): For type 1 and 2A; stimulates release of VWF and factor VIII.
  • Factor VIII Transfusion: For more severe cases.
  • Blood Transfusion: For severe bleeds and anemia.

Acquired Von Willebrand Disease

  • Causes:
    • Aortic stenosis, leading to shear stress on VWF.
    • Mechanical heart valves.
    • Wilms tumor.

  • Conclusion: Understanding vWD is crucial for effective diagnosis and treatment, considering its prevalence and impact.